Thomson Medical Group Limited

Informe acción SGX:A50

Capitalización de mercado: S$1.3b

Thomson Medical Group Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Thomson Medical Group de 14.4% y 6.7% por año respectivamente. Se prevé que el BPA crezca en un 14% al año. Se espera que la rentabilidad financiera sea de 4.2% en 3 años.

Información clave

14.4%

Tasa de crecimiento de los beneficios

14.0%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare18.9%
Tasa de crecimiento de los ingresos6.7%
Rentabilidad financiera futura4.2%
Cobertura de analistas

Low

Última actualización24 Sep 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Earnings Troubles May Signal Larger Issues for Thomson Medical Group (SGX:A50) Shareholders

Sep 02
Earnings Troubles May Signal Larger Issues for Thomson Medical Group (SGX:A50) Shareholders

Calculating The Fair Value Of Thomson Medical Group Limited (SGX:A50)

Apr 01
Calculating The Fair Value Of Thomson Medical Group Limited (SGX:A50)

Should You Think About Buying Thomson Medical Group Limited (SGX:A50) Now?

Dec 16
Should You Think About Buying Thomson Medical Group Limited (SGX:A50) Now?

Here's Why Thomson Medical Group (SGX:A50) Has A Meaningful Debt Burden

Aug 31
Here's Why Thomson Medical Group (SGX:A50) Has A Meaningful Debt Burden

We Ran A Stock Scan For Earnings Growth And Thomson Medical Group (SGX:A50) Passed With Ease

Apr 24
We Ran A Stock Scan For Earnings Growth And Thomson Medical Group (SGX:A50) Passed With Ease

Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet

Mar 27
Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet

Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet

Nov 22
Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet

Should You Be Adding Thomson Medical Group (SGX:A50) To Your Watchlist Today?

Sep 30
Should You Be Adding Thomson Medical Group (SGX:A50) To Your Watchlist Today?

Market Participants Recognise Thomson Medical Group Limited's (SGX:A50) Earnings

Sep 03
Market Participants Recognise Thomson Medical Group Limited's (SGX:A50) Earnings

These 4 Measures Indicate That Thomson Medical Group (SGX:A50) Is Using Debt Reasonably Well

Feb 26
These 4 Measures Indicate That Thomson Medical Group (SGX:A50) Is Using Debt Reasonably Well

We Think Thomson Medical Group (SGX:A50) Can Stay On Top Of Its Debt

Oct 21
We Think Thomson Medical Group (SGX:A50) Can Stay On Top Of Its Debt

We Think Thomson Medical Group (SGX:A50) Has A Fair Chunk Of Debt

Mar 27
We Think Thomson Medical Group (SGX:A50) Has A Fair Chunk Of Debt

Eng Lim Just Bought A Sprinkling of Shares In Thomson Medical Group Limited (SGX:A50)

Feb 20
Eng Lim Just Bought A Sprinkling of Shares In Thomson Medical Group Limited (SGX:A50)

Should You Take Comfort From Insider Transactions At Thomson Medical Group Limited (SGX:A50)?

Jan 27
Should You Take Comfort From Insider Transactions At Thomson Medical Group Limited (SGX:A50)?

Reflecting on Thomson Medical Group's (SGX:A50) Share Price Returns Over The Last Year

Dec 23
Reflecting on Thomson Medical Group's (SGX:A50) Share Price Returns Over The Last Year

Is Thomson Medical Group (SGX:A50) Using Too Much Debt?

Nov 27
Is Thomson Medical Group (SGX:A50) Using Too Much Debt?

Previsiones de crecimiento de beneficios e ingresos

SGX:A50 - Estimaciones futuras de los analistas y datos financieros pasados (SGD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
6/30/2027443231071271
6/30/2026429201011261
6/30/202541516851151
6/30/2024356155383N/A
3/31/202435116104128N/A
12/31/202334516155173N/A
9/30/202335326115131N/A
6/30/2023361377689N/A
3/31/20233705083102N/A
12/31/20223796491115N/A
9/30/20223595978104N/A
6/30/2022339546593N/A
3/31/2022304364875N/A
12/31/2021269193058N/A
9/30/2021255162760N/A
6/30/2021240142461N/A
3/31/2021228-381453N/A
12/31/2020215-89545N/A
9/30/2020215-94250N/A
6/30/2020216-99-255N/A
12/31/201923011168N/A
9/30/201922722362N/A
6/30/201922271749N/A
3/31/201921891948N/A
12/31/2018216111641N/A
9/30/2018212101444N/A
6/30/2018208142351N/A
3/31/201820415N/A47N/A
12/31/201720116N/A52N/A
8/31/201719933N/A49N/A
8/31/201619327N/A44N/A
8/31/201517725N/A41N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (14.4% al año) de A50 es superior a la tasa de ahorro (2.2%).

Beneficios vs. Mercado: Se prevé que los beneficios (14.4% al año) de A50 crezcan más rápidamente que el mercado SG (11.4% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de A50 crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (6.7% al año) de A50 crezcan más rápidamente que los del mercado SG (3.8% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 6.7% al año) de A50 crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de A50 sea baja dentro de 3 años (4.2%).


Descubre empresas en crecimiento